Maze Therapeutics, Inc.
MAZE
$14.49
$1.188.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.11% | 909.58% | 574.98% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 52.49% | -- | -1.88% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.14% | -- | 491.24% | -- | -- |
|
|
|||||
| Total Current Assets | 51.14% | -- | 491.24% | -- | -- |
| Net Property, Plant & Equipment | -13.84% | -- | -14.48% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.07% | -- | 271.49% | -- | -- |
| Total Assets | 40.65% | -- | 236.40% | -- | -- |
|
|
|||||
| Total Accounts Payable | 67.93% | -- | -3.96% | -- | -- |
| Total Accrued Expenses | 8.40% | -- | 43.78% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.17% | -- | 3.19% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.89% | -- | 26.70% | -- | -- |
|
|
|||||
| Total Current Liabilities | -7.89% | -- | 26.70% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.88% | -- | -12.21% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -56.21% | -- | -28.99% | -- | -- |
|
|
|||||
| Common Stock & APIC | 2,468.61% | -- | 116.34% | -- | -- |
| Retained Earnings | -46.96% | -- | 9.42% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 199.95% | 178.12% | 16.76% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 32.35% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 32.35% | -- | -- |
|
|
|||||
| Total Common Equity | 199.95% | 178.12% | 16.76% | -- | -- |
| Total Preferred Equity | -- | -- | 32.35% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 115.78% | 2,804.99% | 1,858.46% | -- | -- |
|
|
|||||